According to new research from global professional services company, Accenture, there is an estimated £22 billion that could be unlocked by pharmaceutical companies over the next 10 years through harnessing digital technologies.
Digital pharma
The research revealed that through investment in digital technologies it may be possible for the pharma industry to accelerate growth by five percent. This growth could translate to an estimated £12 billion in new revenue over the course of a decade. Additionally, it may be possible for companies to reduce their costs by more than £11 billion through implementation of these technologies, which could also then lead to savings of 10% being passed on to the customers.